Approvals/TGA/DESVENLAFAXINE SANDOZ desvenlafaxine 50mg modified release tablets blister

Approved

STANDARD

DESVENLAFAXINE SANDOZ desvenlafaxine 50mg modified release tablets blister

Medis Pharma Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8a1e86f323c7e7d0
Product Name: DESVENLAFAXINE SANDOZ desvenlafaxine 50mg modified release tablets blister
Artg Id: 218083
Artg Name: DESVENLAFAXINE SANDOZ desvenlafaxine 50mg modified release tablets blister
Sponsor: Medis Pharma Pty Ltd
Company Detail Path: /organization/medis-pharma-pty-ltd
Artg Date: 2014-11-26
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-02713-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-02320-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

8a1e86f323c7e7d0

Type

Standard